VF
EVGN icon

Virtu Financial’s Evogene EVGN Stock Holding History

Virtu Financial’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,017
Closed -$41K – 1645
2025
Q2 		$41K Buy
+32,017
New +$39.2K ﹤0.01% 1168
2024
Q2 		– Sell
-1,152
Closed -$9K – 1464
2024
Q1 		$9K Buy
+1,152
New +$9.61K ﹤0.01% 1257
2023
Q4 		– Sell
-1,161
Closed -$7K – 1683
2023
Q3 		$7K Sell
1,161
-1,572
-58% -$13.8K ﹤0.01% 1129
2023
Q2 		$29K Buy
+2,733
New +$18.5K ﹤0.01% 1207
2022
Q4 		– Sell
-1,529
Closed -$13K – 1771
2022
Q3 		$13K Buy
+1,529
New +$14.7K ﹤0.01% 1484
2022
Q2 		– Sell
-3,658
Closed -$48K – 1718
2022
Q1 		$48K Buy
+3,658
New +$49.3K ﹤0.01% 1145
2021
Q1 		– Sell
-5,303
Closed -$249K – 1720
2020
Q4 		$249K Buy
+5,303
New +$187K 0.03% 744
2020
Q3 		– Sell
-1,542
Closed -$15K – 1200
2020
Q2 		$15K Buy
+1,542
New +$16.7K ﹤0.01% 1158

Other funds holding EVGN

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Virtu Financial's EVGN Position: Q3 2025 in Review

Virtu Financial sold out of Evogene (EVGN) in Q3 2025, closing a stake of 32,017 shares — an estimated $41K sold.

Virtu Financial first reported a position in EVGN in Q2 2020 and held it in 8 quarters. The position peaked at $249K in Q4 2020. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2025.

  • Virtu Financial reported no remaining Evogene position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 32,017 Evogene shares in Q3 2025, an estimated $41K.
  • Virtu Financial first reported a position in Evogene in Q2 2020 and held it in 8 quarters.
  • Virtu Financial's Evogene position peaked at $249K in Q4 2020.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.